The IVIG market is expanding on growing demand in immune deficiencies, autoimmune disorders, and neurological conditions. Key firms such as CSL Behring, Takeda, Grifols, and Octapharma are leading in product development and supply chain innovations. Advances in manufacturing, increased diagnosis rates, and rising healthcare access are accelerating market growth — alongside efforts to reduce adverse effects and improve product availability globally. Access Market Report: https://shorturl.at/qJRvG